Janet Lo, MD
Endocrinology, Diabetes & Metabolism · Boston, MANPI 1639290083
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $21,328 of the $21,328 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Viiv Healthcare Company.
Across 8 payments — averaging $2666.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$21K
Across 6 payments — averaging $94,336 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Viiv Healthcare Company$566K
What the payments were for
- Consulting fees$21,328100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 8 | $21,328 |
How this compares
$21,328 in reported general payments places this provider in the 85th percentile of 360 endocrinology, diabetes & metabolism providers in Massachusetts.
See all endocrinology, diabetes & metabolism providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Repatha SureclickEvolocumab | 133 | $165,736 |
| Praluent PenAlirocumab | 47 | $55,545 |
| OzempicSemaglutide | 13 | $15,633 |
| LivaloPitavastatin Calcium | 13 | $12,558 |
| Testosterone | 25 | $7,007 |
| Ezetimibe | 49 | $2,117 |
| Cabergoline | 12 | $1,887 |
| Rosuvastatin Calcium | 37 | $740 |
| Levothyroxine Sodium | 49 | $675 |
| Atorvastatin Calcium | 26 | $286 |
| Metformin Hcl ErMetformin Hcl | 11 | $103 |
Paid to pharmacies, not to this prescriber.
Other endocrinology, diabetes & metabolism in Boston
- Jason GagliaBoston$2.4M
- Vanita ArodaBoston$482K
- Michael RosenblattBoston$447K
- Steven RussellBoston$445K
- Beverly BillerBoston$346K
- Christos MantzorosBoston$243K
- Augusto Caballero-RoblesBoston$150K
- Osama HamdyBoston$117K
- Barbara KahnBoston$105K
- Naomi FisherBoston$79K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.